SGLT2-inhibitors: No Benefit in Hospitalized COVID-19 SGLT2-inhibitors: No Benefit in Hospitalized COVID-19

However, an important take-home message from this new meta-analysis is that these widely used medications appeared to be safe even in acutely ill hospitalized patients, the researchers say.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Cardiology News Source Type: news